Evidence map›Paper›PMID 35884925›Full record

ArticleBiomedicines2022

Kinetin Ameliorates Cisplatin-Induced Hepatotoxicity and Lymphotoxicity via Attenuating Oxidative Damage, Cell Apoptosis and Inflammation in Rats.

Moustafa Fathy, Mostafa A Darwish, Al-Shaimaa M Abdelhamid, Gehad M Alrashedy, Othman Ali Othman, Muhammad Naseem, Thomas Dandekar, Eman M Othman

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Immunomodulatory effect of Qihuang Biwen decoction and its postbiotic product.World journal of microbiology & biotechnology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Moustafa FathyDepartment of Biochemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.ORCID 0000-0002-0734-5007
Mostafa A DarwishDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef 62521, Egypt.ORCID 0000-0003-0897-6385
Al-Shaimaa M AbdelhamidDepartment of Chemistry, Biochemistry Division, Faculty of Science, Minia University, Minia 61519, Egypt.
Gehad M AlrashedyDepartment of Chemistry, Biochemistry Division, Faculty of Science, Minia University, Minia 61519, Egypt.
Othman Ali OthmanDepartment of Chemistry, Biochemistry Division, Faculty of Science, Minia University, Minia 61519, Egypt.
Muhammad NaseemDepartment of Life and Environmental Sciences, College of Natural and Health Sciences, Zayed University, Abu Dhabi 144534, United Arab Emirates.
Thomas DandekarDepartment of Bioinformatics, Biocenter, University of Wuerzburg, Am Hubland, 97074 Wuerzburg, Germany.ORCID 0000-0003-1886-7625
Eman M OthmanDepartment of Biochemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.ORCID 0000-0003-4781-9745
Minia University · EGUniversity of Würzburg · DENahda University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Though several previous studies reported the in vitro and in vivo antioxidant effect of kinetin (Kn), details on its action in cisplatin-induced toxicity are still scarce. In this study we evaluated, for the first time, the effects of kinetin in cisplatin (cp)- induced liver and lymphocyte toxicity in rats. Wistar male albino rats were divided into nine groups: (i) the control (C), (ii) groups 2,3 and 4, which received 0.25, 0.5 and 1 mg/kg kinetin for 10 days; (iii) the cisplatin (cp) group, which received a single intraperitoneal injection of CP (7.0 mg/kg); and (iv) groups 6, 7, 8 and 9, which received, for 10 days, 0.25, 0.5 and 1 mg/kg kinetin or 200 mg/kg vitamin C, respectively, and Cp on the fourth day. CP-injected rats showed a significant impairment in biochemical, oxidative stress and inflammatory parameters in hepatic tissue and lymphocytes. PCR showed a profound increase in caspase-3, and a significant decline in AKT gene expression. Intriguingly, Kn treatment restored the biochemical, redox status and inflammatory parameters. Hepatic AKT and caspase-3 expression as well as CD95 levels in lymphocytes were also restored. In conclusion, Kn mitigated oxidative imbalance, inflammation and apoptosis in CP-induced liver and lymphocyte toxicity; therefore, it can be considered as a promising therapy.

Indexed as

AKTcaspase-3CD95cisplatinhepatotoxicitylymphotoxicityoxidative stress

Identifiers

PMID35884925
PMCPMC9312964
OpenAlexW4284674137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.